Apollo Global Management LLC Class A (APO)vsBlackRock Health Sciences Trust II (BMEZ)
APO
Apollo Global Management LLC Class A
$109.80
-1.30%
FINANCIAL SERVICES · Cap: $64.57B
BMEZ
BlackRock Health Sciences Trust II
$14.00
+1.38%
FINANCIAL SERVICES · Cap: $860.02M
Smart Verdict
WallStSmart Research — data-driven comparison
APO leads profitability with a 11.0% profit margin vs 0.0%. BMEZ trades at a lower P/E of 5.4x. APO earns a higher WallStSmart Score of 63/100 (C+).
APO
Buy63
out of 100
Grade: C+
BMEZ
Avoid30
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-237.0%
Fair Value
$37.67
Current Price
$109.80
$72.13 premium
Margin of Safety
+12.7%
Fair Value
$17.27
Current Price
$14.00
$3.27 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 87.7% year-over-year
Large-cap with strong market position
Reasonable price relative to book value
Generating 2.8B in free cash flow
Attractively priced relative to earnings
Areas to Watch
Weak financial health signals
Earnings declined 57.3%
Distress zone — elevated risk
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : APO
The strongest argument for APO centers on Revenue Growth, Market Cap, Price/Book. Revenue growth of 87.7% demonstrates continued momentum. PEG of 1.21 suggests the stock is reasonably priced for its growth.
Bull Case : BMEZ
The strongest argument for BMEZ centers on P/E Ratio.
Bear Case : APO
The primary concerns for APO are Piotroski F-Score, EPS Growth, Altman Z-Score.
Bear Case : BMEZ
The primary concerns for BMEZ are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
APO profiles as a growth stock while BMEZ is a value play — different risk/reward profiles.
APO is growing revenue faster at 87.7% — sustainability is the question.
APO generates stronger free cash flow (2.8B), providing more financial flexibility.
Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.
Bottom Line
APO scores higher overall (63/100 vs 30/100) and 87.7% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Apollo Global Management LLC Class A
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Apollo Global Management LLC Class A (APO) is a leading global alternative investment firm, specializing in private equity, credit, and real estate across a wide array of sectors such as healthcare, financial services, and technology. The firm employs a disciplined investment strategy that leverages deep industry expertise and operational insight to enhance portfolio value. With a strong commitment to long-term growth, Apollo seeks to identify and capitalize on strategic investment opportunities in both developed and emerging markets. As a publicly traded entity, it aims to deliver attractive risk-adjusted returns to investors through its substantial capital resources and strategic initiatives.
BlackRock Health Sciences Trust II
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund actively managed to deliver high total returns through a diversified portfolio primarily focused on the health sciences sector, encompassing pharmaceuticals, biotechnology, and medical devices. Backed by the expertise of BlackRock, a leading global investment manager, BMEZ capitalizes on the significant growth potential and innovation trends driven by demographic changes and increased healthcare expenditures. With a disciplined investment approach, this fund represents an appealing opportunity for institutional investors seeking to capitalize on the dynamic and evolving landscape of health sciences, thereby enhancing their overall investment strategies.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?